PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35280304-6	2022	Results: Significant differences were identified in the expression levels of interferon-gamma (IFN-gamma) (P < 0.001), interleukin (IL)-6 (P = 0.008) and tumor necrosis factor-alpha (TNF-alpha) (P = 0.036) in the luminal fluid of the ES comparing between the MD and AN groups.	Phenobarbital	213-220	tumor necrosis factor	Homo sapiens	154-181	
35280304-6	2022	Results: Significant differences were identified in the expression levels of interferon-gamma (IFN-gamma) (P < 0.001), interleukin (IL)-6 (P = 0.008) and tumor necrosis factor-alpha (TNF-alpha) (P = 0.036) in the luminal fluid of the ES comparing between the MD and AN groups.	Phenobarbital	213-220	tumor necrosis factor	Homo sapiens	183-192	
33926547-2	2021	METHODS: In the current study, we investigated TNF-alpha modulated mitochondrial proteome using high-resolution mass spectrometry and identified the differentially expressed proteins in two different breast cancer cell lines, ER/PR positive cell line; luminal, MCF-7 and ER/PR negative cell line; basal-like, MDA-MB-231 and explored its implication in regulating the tumorigenic potential of breast cancer cells.	Phenobarbital	252-259	tumor necrosis factor	Homo sapiens	47-56	
33342810-10	2020	Moreover, mean transcript levels of TNF-alpha and NF-kappaB1 were significantly elevated in Luminal A and Luminal B subtypes of breast cancer patients, respectively.	Phenobarbital	92-99	tumor necrosis factor	Homo sapiens	36-45	
33342810-10	2020	Moreover, mean transcript levels of TNF-alpha and NF-kappaB1 were significantly elevated in Luminal A and Luminal B subtypes of breast cancer patients, respectively.	Phenobarbital	106-113	tumor necrosis factor	Homo sapiens	36-45